iSeed exits MySugr in trade sale to Roche
Swiss pharmaceutical business Roche Holding has purchased Austrian diabetes application developer MySugr, enabling the exit of VC backers.
MySugr will continue to operate as an independent brand in the group and plans to expand its teams in Vienna and San Diego. The acquisition is part of Roche's new diabetes care strategy.
In March 2015, iSeed Ventures led a $4.8m funding round for MySugr. Roche Ventures and XLHealth also participated in the round. It was iSeed's first investment outside of the US and China.
Company
Founded in 2012 and headquartered in Vienna, MySugr provides digital services for people with diabetes. The business develops the MySugr Logbook app for diabetes management, which operates on a freemium ad-supported model, and runs the MySugr Academy education platform. The company employs around 70 people.
People
MySugr – Frank Westermann (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









